Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy

Japanese Journal of Clinical Oncology

Volumn 35, Issue 1, 2005, Pages 1-5

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Kim, Chul Woo ^a   Kim, Il Han ^a   Park, Charn Il ^a  

^a Seoul National University   (South Korea)

Author keywords

Angiocentric T cell lymphoma; Chemoradiotherapy; NK T cell lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COBALT THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NOSE TUMOR; OUTCOMES RESEARCH; STATISTICAL SIGNIFICANCE; T CELL LYMPHOMA; IMMUNOPHENOTYPING; MIDDLE AGED; MORTALITY; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NOSE NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 14944369300     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyi006     Document Type: Article

References (19)

1. Chen HHW, Fong L, Su IJ, Ting LL, Hong RL, Leung HWC, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 1996;38:1-6.
2. Sakata KI, Hareyama M, Ohuchi A, Sido M, Nagakura H, Morita K, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 1997;36:307-11.
3. Itami J, Itami M, Mikata A, Tamaru JI, Kaneko T, Ogata H, et al. Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 1991;20: 797-802.
4. Smalley SR, Cupps RE, Anderson JA, Ilstrup DM, McDonald TJ, Weiland LH, et al. Polymorphic reticulosis limited to the upper aerodigestive tract. Natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys 1988;15:599-605.
5. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991;22: 1150-7.
6. Harris EC, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
7. Harris EC, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
8. Aviles A, Rodriguez L, Guzman R, Talavera A, Garcia EL, Diaz-Maqueo JC. Angiocentric T-cell lymphoma of the nose, paranasal sinus and hard palate. Hematol Oncol 1992;10:141-7.
9. Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PTM, Ng CS, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-77.
10. Jaffe ES, Chan JKC, So IJ, Frizzera G, Mori S, Feller AC, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996;20:103-11.
11. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63.
12. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, et al. REAL classification of malignant lymphomas in the Republic of Korea. Cancer 1998;83:806-12.
13. Liang R, Todd D, Chan TK, Chin E, Lie A, Kwong YL, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-70.
14. Kim GE, Lee S, Chang SK, Park HC, Pyo HR, Kim JH, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001;61:261-9.
15. Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 2001;12:349-52.
16. Cheung MMC, Chan JKC, Lau WH, Ngan RKC, Foo WWL. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002;54:182-90.
17. Ribrag V, Hajj ME, Janot F, Girinsky T, Domenge C, Schwaab G, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001;15:1123-6.
18. Aviles A, Diaz NR, Neri N, Cleto S, Talavera A. Angiocentric nasal T/natural killer cell lymphoma: a single center study of prognostic factors in 108 patients. Clin Lab Haematol 2000;22:215-20.
19. Kaplan EL, Meier PI. A nonparametric estimation from incomplete observations. J Am Statics Assoc 1958;53:457-81.